SAM
REGN icon

Smartleaf Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Smartleaf Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$635K Buy
846
+137
+19% +$105K 0.02% 485
2025
Q4 		$549K Sell
709
-32
-4% -$21.7K 0.02% 510
2025
Q3 		$416K Buy
741
+188
+34% +$106K 0.03% 520
2025
Q2 		$288K Sell
553
-307
-36% -$171K 0.03% 494
2025
Q1 		$548K Sell
860
-92
-10% -$63.3K 0.05% 340
2024
Q4 		$669K Buy
952
+72
+8% +$60.4K 0.07% 280
2024
Q3 		$918K Buy
880
+213
+32% +$237K 0.11% 205
2024
Q2 		$701K Buy
667
+186
+39% +$180K 0.11% 201
2024
Q1 		$465K Buy
481
+217
+82% +$206K 0.09% 226
2023
Q4 		$233K Buy
+264
New +$217K 0.06% 297

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Smartleaf Asset Management's REGN Position: Q1 2026 in Review

Smartleaf Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 19% in Q1 2026, buying an estimated $105K and bringing the position to 846 shares worth $635K. The position accounts for 0.02% of the portfolio, ranked #485.

Smartleaf Asset Management first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $918K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Smartleaf Asset Management held 846 shares of Regeneron Pharmaceuticals worth $635K as of Q1 2026.
  • Smartleaf Asset Management bought 137 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $105K.
  • Regeneron Pharmaceuticals made up 0.02% of Smartleaf Asset Management's portfolio in Q1 2026, its #485 holding.
  • Smartleaf Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Regeneron Pharmaceuticals position peaked at $918K in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.